Jazz Pharmaceuticals' IPO: Taking Stock of VC Dilution
This article was originally published in Start Up
Executive Summary
The stockholder breakdown in Jazz Pharmaceuticals demonstrates how the company's founding VCs were significantly diluted by that company's massive Series B in 2004. As the company prepares for IPO it's worth considering how Ikaria Holdings' backers last month pulled in private equity support and managed to maintain their stakes in the company.